We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Pulls Bipolar Drug After Lackluster Trial Results
The item has been added to your shopping cart.
Teva Pulls Bipolar Drug After Lackluster Trial Results
September 6, 2013
Teva has pulled the plug on developing a new indication for its sleep disorder drug Nuvigil to treat bipolar I disorder after poor efficacy results from a final Phase III trial.